This facilitates tissue-specific internalization via recognition by cell surface receptors (e.g., LDLR, SR-B1, especially for targeting the liver), membrane fusion, or endocytosis, and protects siRNA from renal filtration, thereby leading to more tumor penetration [39]. The gene discussed is SCARB1; the disease is neoplasm.